Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A highly precise reporter gene bioassay for type I interferon

U Canosi1, M Mascia, L Gazza

  • 1Instituto di Ricerca Cesare Serono SpA, Rome, Italy.

Journal of Immunological Methods
|November 29, 1996
PubMed
Summary

A new reporter gene assay for type I interferons (IFNs) was developed using monkey Vero cells. This highly precise and efficient assay provides rapid quantification of IFN-alpha and IFN-beta levels within one day.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radon isotopes as tracers of climate-sensitive subsurface connectivity in Antarctic permafrost.

Environmental research·2026
Same author

Efgartigimod as Add-On Treatment in Refractory Guillain-Barré Syndrome: A Case Report.

European journal of neurology·2025
Same author

Processing factors of pesticide residues in durum wheat milling fractions and pasta.

Food chemistry·2025
Same author

Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Imaging the Meissner effect in hydride superconductors using quantum sensors.

Nature·2024
Same author

PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers.

ESMO open·2022

Area of Science:

  • Immunology
  • Molecular Biology
  • Biotechnology

Background:

  • Type I interferons (IFNs) are crucial cytokines in innate immunity.
  • Accurate and efficient assays are needed for quantifying type I IFN activity.
  • Existing bioassays for IFNs can be time-consuming and less efficient.

Purpose of the Study:

  • To establish and validate a novel reporter gene assay for type I IFN.
  • To develop a rapid, precise, and efficient method for IFN quantification.
  • To compare the new assay's performance with existing methods.

Main Methods:

  • Stable transfection of monkey Vero cells with pMx-Luc plasmid containing a luciferase reporter gene under the IFN-inducible Mx1 promoter.
  • Selection of a clone (3-143/5) exhibiting robust luciferase inducibility by IFN-beta.

Related Experiment Videos

  • Application of a 3x3 balanced parallel line assay design with a 96-well luminometer for routine measurements.
  • Dose-response analysis and specificity testing against various cytokines.

    • Main Results:

    • A linear dose-response relationship was observed for IFN-beta in the range of 1-16 IU/ml.
    • The assay demonstrated high specificity for IFN-alpha and IFN-beta, with no cross-reactivity to IFN-gamma or other tested cytokines.
    • The assay is highly precise (coefficient of variation <9%) and efficient, with a short assay duration of 1 day.
    • The reporter gene assay is significantly faster than classical cytopathic effect assays and a previously published growth hormone-based assay.

    Conclusions:

    • The developed reporter gene assay is a precise, efficient, and specific method for quantifying type I IFNs.
    • This assay offers a significant advantage in terms of speed and efficiency for routine IFN analysis.
    • The assay provides a valuable tool for research and clinical applications involving type I interferons.